PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
YINN vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

YINN vs. CURE

Last updated Jun 13, 2026

YINN (Direxion Daily China 3x Bull Shares) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds from Direxion - YINN tracks the FTSE China 50 Index (300%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, YINN returned -18.37%/yr vs 13.49%/yr for CURE. At a 0.38 correlation, their price movements are largely independent. YINN charges 1.52%/yr vs 1.08%/yr for CURE.

Performance

YINN vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily China 3x Bull Shares (YINN) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, YINN achieves a -29.95% return, which is significantly lower than CURE's -7.96% return. Over the past 10 years, YINN has underperformed CURE with an annualized return of -18.37%, while CURE has yielded a comparatively higher 13.49% annualized return.

YINN

1D
3.08%
1M
-23.37%
YTD
-29.95%
6M
-32.53%
1Y
-27.68%
3Y*
-6.43%
5Y*
-38.50%
10Y*
-18.37%

CURE

1D
-0.55%
1M
13.53%
YTD
-7.96%
6M
-6.00%
1Y
26.46%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

YINN vs. CURE - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
YINN
Direxion Daily China 3x Bull Shares		-29.95%54.21%36.06%-53.08%-71.97%-58.56%-7.75%28.92%-48.47%129.79%
CURE
Direxion Daily Healthcare Bull 3x Shares		-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between YINN and CURE is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.38

The correlation between YINN and CURE shifts across timeframes, from 0.20 (3 years) to 0.38 (all time), reflecting how their relationship changes across market environments.

YINN vs. CURE - Sectors Allocation Comparison

Sectors
YINN
CURE

Financial Services

34.7%

-

Consumer Cyclical

27.4%

-

Communication Services

15.7%

-

Energy

5.6%

-

Technology

5.5%

-

Basic Materials

4.2%

-

Industrials

2.4%

-

Healthcare

2.3%
100.0%

Real Estate

1.0%

-

Consumer Defensive

0.9%

-

Utilities

0.4%

-

Financial Services

YINN
34.7%
CURE

-

Consumer Cyclical

YINN
27.4%
CURE

-

Communication Services

YINN
15.7%
CURE

-

Energy

YINN
5.6%
CURE

-

Technology

YINN
5.5%
CURE

-

Basic Materials

YINN
4.2%
CURE

-

Industrials

YINN
2.4%
CURE

-

Healthcare

YINN
2.3%
CURE
100.0%

Real Estate

YINN
1.0%
CURE

-

Consumer Defensive

YINN
0.9%
CURE

-

Utilities

YINN
0.4%
CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Direxion Daily China 3x Bull Shares

Direxion Daily Healthcare Bull 3x Shares

Often compared with YINN:
YINN vs. YANGYINN vs. KWEBYINN vs. CWEBYINN vs. CHAUYINN vs. XPPYINN vs. EDCYINN vs. MCHI
Often compared with CURE:
CURE vs. XLVCURE vs. RXLCURE vs. PILLCURE vs. UTSLCURE vs. CNRGCURE vs. CWEBCURE vs. RETL

Return for Risk

YINN vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
YINN
YINN Risk / Return Rank: 66
Overall Rank
YINN Sharpe Ratio Rank: 55
Sharpe Ratio Rank
YINN Sortino Ratio Rank: 66
Sortino Ratio Rank
YINN Omega Ratio Rank: 66
Omega Ratio Rank
YINN Calmar Ratio Rank: 55
Calmar Ratio Rank
YINN Martin Ratio Rank: 55
Martin Ratio Rank
CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

YINN vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily China 3x Bull Shares (YINN) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

YINNCUREDifference
Sharpe ratioReturn per unit of total volatility
-0.47
0.60

-1.07

Sortino ratioReturn per unit of downside risk
-0.36
1.18

-1.55

Omega ratioGain probability vs. loss probability

0.96

1.13

-0.17

Calmar ratioReturn relative to maximum drawdown

-0.56

0.85

-1.41

Martin ratioReturn relative to average drawdown

-1.09

1.94

-3.02

YINN vs. CURE - Sharpe Ratio Comparison

The current YINN Sharpe Ratio is -0.47, which is lower than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of YINN and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

YINN vs. CURE - Drawdown Comparison

The maximum YINN drawdown since its inception was -98.87%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for YINN and CURE.

Loading charts...

Drawdown Indicators

YINNCUREDifference

Max Drawdown

Largest peak-to-trough decline

-98.87%

-69.19%

-29.68%

Max Drawdown (1Y)

Largest decline over 1 year

-49.61%

-31.10%

-18.51%

Max Drawdown (3Y)

Largest decline over 3 years

-69.08%

-51.93%

-17.15%

Max Drawdown (5Y)

Largest decline over 5 years

-96.28%

-52.23%

-44.05%

Max Drawdown (10Y)

Largest decline over 10 years

-98.59%

-69.19%

-29.40%

Current Drawdown

Current decline from peak

-97.52%

-26.94%

-70.58%

Average Drawdown

Average peak-to-trough decline

-68.51%

-18.16%

-50.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.53%

13.71%

+11.82%

Volatility

YINN vs. CURE - Volatility Comparison

Direxion Daily China 3x Bull Shares (YINN) has a higher volatility of 18.63% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 14.30%. This indicates that YINN's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

YINNCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.63%

14.30%

+4.33%

Volatility (6M)

Calculated over the trailing 6-month period

42.54%

30.87%

+11.67%

Volatility (1Y)

Calculated over the trailing 1-year period

58.74%

44.32%

+14.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

94.19%

43.84%

+50.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.73%

49.59%

+32.14%

YINN vs. CURE - Expense Ratio Comparison

YINN has a 1.52% expense ratio, which is higher than CURE's 1.08% expense ratio.

Dividends

YINN vs. CURE - Dividend Comparison

YINN's dividend yield for the trailing twelve months is around 1.42%, more than CURE's 1.16% yield.

PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares		1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
YINN
Direxion Daily China 3x Bull Shares		1.42%1.12%1.81%4.17%1.16%0.73%0.76%1.38%1.02%1.11%

Frequently Asked Questions

YINN and CURE have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

YINN has higher volatility (18.63%) compared to CURE (14.30%). In terms of maximum drawdown, YINN dropped -98.87% vs CURE's -69.19%.

On 10-year performance, CURE leads with 13.49% vs -18.37% for YINN. On fees, CURE is cheaper at 1.08% per year. On volatility, CURE has been the lower-risk option at 14.30%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 13.49% return vs -18.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CURE is cheaper with a 1.08% expense ratio, compared with 1.52% for YINN.

YINN has the higher dividend yield at 1.42%, compared with 1.16% for CURE.

YINN tracks FTSE China 50 Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.52% for YINN and 1.08% for CURE.

CURE currently has the higher Sharpe Ratio (0.60 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for YINN and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer